Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer

BACKGROUND: The International Duration Evaluation of Adjuvant chemotherapy project investigated whether a shorter duration of oxaliplatin-based adjuvant chemotherapy was as effective as 6 months of identical chemotherapy for resected stage III colon cancer. As part of this project, we report safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotaka, Masahito, Yamanaka, Takeharu, Yoshino, Takayuki, Manaka, Dai, Eto, Tetsuya, Hasegawa, Junichi, Takagane, Akinori, Nakamura, Masato, Kato, Takeshi, Munemoto, Yoshinori, Nakamura, Fumitaka, Bando, Hiroyuki, Taniguchi, Hiroki, Gamoh, Makio, Shiozawa, Manabu, Saji, Shigetoyo, Maehara, Yoshihiko, Mizushima, Tsunekazu, Ohtsu, Atsushi, Mori, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922566/
https://www.ncbi.nlm.nih.gov/pubmed/29713499
http://dx.doi.org/10.1136/esmoopen-2018-000354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922566/
https://www.ncbi.nlm.nih.gov/pubmed/29713499
http://dx.doi.org/10.1136/esmoopen-2018-000354

Ejemplares similares